Ustekinumab forhindrer, at IL- 12 og IL- 23 bidrager til aktivering af immunceller, f. eks. intracellulær signalering og udskillelse af cytokiner.
Ustekinumab prevents IL-12 and IL-23 contributions to immune cell activation, such as intracellular signaling and cytokine secretion.